Literature DB >> 6977484

Genetic regulation of delayed-type hypersensitivity responses to poly (Tyr,Glu)-poly(DLAla)--poly(Lys): expression of the genetic defect in the induction and manifestation phases in H-2s and H-2f mice.

G Strassman, E Mozes, Z Eshhar.   

Abstract

The genetic defect of H-2s and H-2s non-responder mouse strains in both the induction and manifestation phases of delayed-type hypersensitivity (DTH) responses to poly(LTyr,LGlu)-poly(DLAla)--poly(LLys)[(T,G)-A--L] was analysed. Utilizing an in vitro system to activate DTH effector T cells, we observed that non-adherent T cells of (H-2f X H-2b) F1 or (H-2s X H-2b)F1 responder mice, could not be activated on antigen bearing adherent cells of H-2f or H-2s haplotypes. On the other hand, these T cells were effectively sensitized on adherent cells derived from either F1 or parental (H-2b) responder mice. These results indicate that in these mouse strains the genetic defect, in the induction phase of DTH, is expressed at the level of the antigen presenting cell. In subsequent experiments, we were able to "correct' the non-responsiveness of H-2s recipients by transfer of educated and irradiated (H-2s X H-2b)F1 T cells together with normal F1 adherent cells. Normal non-adherent and nylon wool enriched T cells failed to restore these responses. Similarly, antigen-pulsed F1 irradiated peritoneal exudate cells could stimulate DTH responses in SJL recipients of (SJL X C57BL/6)F1 (T,G)-A--L educated cells. The genetic defect of H-2s mice in the manifestation phase of the DTH reaction is thus also expressed on the antigen presenting cell.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977484      PMCID: PMC1555233     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Influence of thymus genotype on acquisition of responsiveness in delayed-type hypersensitivity.

Authors:  J F Miller; J Gamble; P Mottram; F I Smith
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

Review 3.  Antigenicity: some molecular aspects.

Authors:  M Sela
Journal:  Science       Date:  1969-12-12       Impact factor: 47.728

4.  Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type.

Authors:  H O McDevitt; A Chinitz
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

5.  A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice.

Authors:  M A Vadas; J F Miller; J Gamble; A Whitelaw
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

6.  The role of thymus cells in the immune response to poly(Tyr, Glu)-polyD L Ala--polyLys as a function of the genetic constitution of the mouse strain.

Authors:  L Lichtenberg; E Mozes; G M Shearer; M Sela
Journal:  Eur J Immunol       Date:  1974-06       Impact factor: 5.532

7.  The role of H-2-linked genes in helper T-cell function. VI. Expression of Ir genes by helper T cells.

Authors:  P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

8.  Histocompatibility linked immune responsiveness and restrictions imposed on sensitized lymphocytes.

Authors:  J F Miller; M A Vadas; A Whitelaw; J Gamble; C Bernard
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

9.  T-lymphocyte-enriched murine peritoneal exudate cells. IV. Genetic control of cross-stimulation at the T-cell level.

Authors:  R H Schwartz; C L Horton; W E Paul
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Antigen-specific T-cell factors in the genetic control of the immune response to poly(Tyr,Glu)-polyDLAla--polyLys. Evidence for T- and B-cell defects in SJL mice.

Authors:  E Mozes; R Isac; M J Taussig
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.